N/A N=150 Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty
Venous Thromboembolism · Arthroplasty
Primary: Deep Vein Thrombosis — 0; 1 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=19 SXC-2023 Cocaine Interaction Study
Cocaine Use Disorder
Primary: Total Number of Treatment-Emergent Adverse Events (Safety and Tolerability) of Oral SXC-2023 Co-administered With Intravenous Cocaine — 99; 132 events
N/A N=64 Scotchbond Universal Plus Compared to Scotchbond Universal With Filtek Universal Restorative to Restore Class V NCCLs
Class V Non-carious Cervical Dental Lesions
Primary: Retention of Restorative Material — 83; 85; 17; 15 percentage of restorations
Phase 3 N=959 Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
Hepatocellular Carcinoma
Primary: Recurrence-Free Survival (RFS) — 46.7; 45.5 Months — p=0.7190
Phase 4 N=168 Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence
Urgency Urinary Incontinence
Primary: Responder (Yes/no) — 23; 39; 36; 17 Participants
N/A N=238 A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
Physician Workflow · Artificial Intelligence (AI)
Primary: Change in the Time in Notes Per Note — -0.85; -0.46; -0.29 ln(minutes per note)
N/A N=114 Relationship Between Preoperative Anxiety, Postoperative Pain, and Emergence Delirium in Pediatric Surgery
Postoperative Pain · Preoperative Anxiety · Emergence Delirium in Pediatric Anesthesia
Primary: Postoperative Pain Intensity — 1; 1; 3; 1 score
N/A N=2 3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
Abdominal Aortic Aneurysm
Primary: Number of Participants With Successful Implantation of Cook Zenith AAA Endovascular Graft Using the 3D-GN&C Device — 2 Participants
N/A N=533 A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers
Opioid Misuse
Primary: Percentage Reporting 'Great Perceived Risk of Harm' From Opioid Misuse — 66; 53 Participants
N/A N=889 Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
Anxiety Disorder · Cognitive/Functional Effects · Colorectal Cancer
Primary: Disease-free Survival — 80.3; 73.9 percentage of participants — p=0.02
Phase 1 N=20 A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure
Heart Failure
Primary: To Investigate the Safety, Tolerability, Efficacy, and On-body Performance of a Novel Patch Infusor Device and Novel Furosemide Formulation Combination (SQIN-01) — 3; 1…
Phase 3 N=238 Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
COPD · Eosinophilia
Primary: Time From Randomisation to Next Hospital Readmission or Death (All Cause) — 25.7; 24.4 Weeks — p=0.811
N/A N=24 The Personal Patient Profile Decision Support for Patients With Bladder Cancer
Bladder Cancer
Primary: Percent of Participants Who Agree Using the Acceptability Scale — 71.4; 62.5; 62.5; 62.5 percentage of participants
N/A N=97 An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
Orthopedic Disorder · Trauma · Ankle Fractures
Primary: Changes in the Ankle Joint Space Width Between Baseline and Final Follow-up — 0.912 mm
Phase 4 N=155 A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
Narcolepsy
Primary: Change From Baseline to End of Treatment (EOT) Visit on the 24-hour Average Systolic Blood Pressure (SBP) in mmHg — -4.14 mmHg